Clinical Trials Directory

Trials / Completed

CompletedNCT04332926

Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study aims to better understand how e-cigarettes (ECIG) nicotine flux impacts several behavioral economic measures of abuse liability.

Conditions

Interventions

TypeNameDescription
OTHERTobacco product administration and assessment, own brand cigarettes4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment
OTHERTobacco product administration and assessment, ECIG 30 Watts, 0 mg/ml nicotine4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment
OTHERTobacco product administration and assessment, ECIG 30 Watts, 8 mg/ml nicotine4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment
OTHERTobacco product administration and assessment, ECIG 30 Watts, 15 mg/ml nicotine4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment
OTHERTobacco product administration and assessment, ECIG 30 Watts, 30 mg/ml nicotine4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment

Timeline

Start date
2021-01-05
Primary completion
2023-06-01
Completion
2023-09-08
First posted
2020-04-03
Last updated
2025-02-13
Results posted
2025-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04332926. Inclusion in this directory is not an endorsement.